(Stroke. 1997;28:1666-1670.)
© 1997 American Heart Association, Inc.
Articles |
From the Department of Neurosurgery, Toyama Medical and Pharmaceutical University (Y.H., M.K., S.E., A.T.), Toyami-shi, Toyama; Department of Cell and Molecular Biology, Primate Research Institute, Kyoto University (S.N.), Inuyama-shi, Aichi; and Department of Neurosurgery, Iwate Medical University (M.S., A.O.), Morioka-shi, Iwate, Japan.
Correspondence and reprint requests to Dr Yutaka Hirashima, Department of Neurosurgery, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-01, Japan. E-mail yhira{at}ms.toyama-mpu.ac.jp.
Background and Purpose No marker that reflects and predicts brain injury due to subarachnoid hemorrhage (SAH) and cerebral vasospasm has been reported. We hypothesized that membrane-bound tissue factor (mTF) and thrombinantithrombin III complex (TAT) in the cerebrospinal fluid (CSF) of patients with SAH become markers indicating brain injury. To evaluate the hypothesis, we correlated levels of mTF and TAT in the CSF of patients with SAH with clinical severity, the degree of SAH, and outcome.
Methods We assayed CSF mTF, TAT and myelin basic protein (MBP) in patients with SAH at intervals that included days 0 to 4 and days 5 to 9 after ictus. Classification of clinical severity of disease on admission was based on Hunt and Hess grade, degree of SAH on CT on Fisher's grading, and outcome 3 months after SAH on the Glasgow Outcome Scale.
Results In the interval from days 0 to 4, mTF and TAT correlated with Hunt and Hess and Fisher grades, and occurrence of cerebral infarction due to vasospasm. Only mTF correlated significantly in this period with outcome. TAT, mTF, and MBP all correlated significantly with each other. From days 5 to 9, only mTF correlated with cerebral infarction, infarction volume, MBP levels, and outcome.
Conclusions Both mTF and TAT reflected brain injury from SAH and predicted vasospasm, though mTF was more sensitive and a better predictor of outcome. Unlike mTF, TAT did not correlate with vasospasm during the interval when it most commonly occurs, which raised doubt about thrombin activation as a cause.
Key Words: cerebral vasospasm procoagulants subarachnoid hemorrhage cerebrospinal fluid thrombin
This article has been cited by other articles:
![]() |
H. Tsurutani, H. Ohkuma, and S. Suzuki Effects of Thrombin Inhibitor on Thrombin-Related Signal Transduction and Cerebral Vasospasm in the Rabbit Subarachnoid Hemorrhage Model Stroke, June 1, 2003; 34(6): 1497 - 1500. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, I. Nagata, H. Kikuchi, J-H. Xue, N. Sakai, H. Sakai, and H. Yanamoto Broad-Spectrum and Selective Serine Protease Inhibitors Prevent Expression of Platelet-Derived Growth Factor-BB and Cerebral Vasospasm After Subarachnoid Hemorrhage : Vasospasm Caused by Cisternal Injection of Recombinant Platelet-Derived Growth Factor-BB Stroke, July 1, 2001; 32(7): 1665 - 1672. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |